Pillstats
Rx only · Tablet, Film Coated, Extended Release · Oral

Ranolazine

Ranolazine

21 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US41 NDCs
21 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC01EB18
RxCUI (US)35829
US makers21 labelers
Packages76
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 21 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.065$0.131$0.196$0.261Dec 2025Apr 2026Jul 2026
$0.217
Latest avg · Jul 22, 2026
-5%
Since Dec 17, 2025
21
Active US suppliers
30%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

9.7K19K29K39K2025 Q12025 Q22025 Q32025 Q42026 Q1
29K
Rx · 2026 Q1
2.3M
Units dispensed
-8%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it21 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown15SUPPLYING
Aurobindo Pharma Limitedunknown8SUPPLYING
SunGen Pharma LLCunknown6SUPPLYING
Unichem Pharmaceuticals (USA), Inc.unknown6SUPPLYING
ScieGen Pharmaceuticals, Inc.unknown6SUPPLYING
Ascend Laboratories, LLCunknown6SUPPLYING
Glenmark Pharmaceuticals Inc., USAunknown4SUPPLYING
Aphena Pharma Solutions - Tennessee, LLCunknown3SUPPLYING
Torrent Pharma, Inc.unknown2SUPPLYING
i3 Pharmaceuticals, LLCunknown2SUPPLYING
A2A Integrated Pharmaceuticalsunknown2SUPPLYING
AvKAREunknown2SUPPLYING
RADHA PHARMACEUTICALS, INC.unknown2SUPPLYING
Zameer Pharmaceuticals LLCunknown2SUPPLYING
Camber Pharmaceuticals, Inc.unknown2SUPPLYING

+ 6 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 13, 2025
    RECALLRecall (Class II): Ranolazine Extended-Release Tablets 1000mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limit…

    CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide

  • Oct 23, 2023
    RECALLRecall (Class II): Ranolazine Extended-Release Tablets 500mg, 60 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Li…

    Failed Dissolution Specifications: Out of specification for dissolution. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide